BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1873308)

  • 1. Simultaneous determination of levodopa, its main metabolites and carbidopa in plasma by liquid chromatography.
    Wikberg T
    J Pharm Biomed Anal; 1991; 9(2):167-76. PubMed ID: 1873308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection.
    Saxer C; Niina M; Nakashima A; Nagae Y; Masuda N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):299-305. PubMed ID: 15018791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous high-performance liquid chromatographic analysis of carbidopa, levodopa and 3-O-methyldopa in plasma and carbidopa, levodopa and dopamine in urine using electrochemical detection.
    Titus DC; August TF; Yeh KC; Eisenhandler R; Bayne WF; Musson DG
    J Chromatogr; 1990 Dec; 534():87-100. PubMed ID: 2094725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid.
    Karimi M; Carl JL; Loftin S; Perlmutter JS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):120-3. PubMed ID: 16584928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian phase dependent pharmacokinetics of L-dopa, its main metabolites (3-OMD, HVA, DOPAC) and carbidopa in rats.
    Andre MH; Grignon S; Bruguerolle B
    Fundam Clin Pharmacol; 1996; 10(4):350-5. PubMed ID: 8871134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of carbidopa, levodopa and 3,4-dihydroxyphenyl-acetic acid using high-performance liquid chromatography with electrochemical detection.
    Nissinen E; Taskinen J
    J Chromatogr; 1982 Sep; 231(2):459-62. PubMed ID: 7130324
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous intravenous monitoring of levodopa and 3-O-methyldopa by microdialysis and high-performance liquid chromatography with electrochemical detection.
    Deleu D; Sarre S; Herregodts P; Ebinger G; Michotte Y
    J Pharm Biomed Anal; 1991; 9(2):159-65. PubMed ID: 1873307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.
    Vilhena Rde O; Pontes FL; Marson BM; Ribeiro RP; de Carvalho KA; Cardoso MA; Pontarolo R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():41-9. PubMed ID: 25063927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous estimation of levodopa, carbidopa and 3-oxymethyldopa in rat plasma using HPLC-ECD.
    Raut PP; Charde SY; Bishnoi P
    Biomed Chromatogr; 2016 Oct; 30(10):1696-700. PubMed ID: 26910491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma.
    César IC; Byrro RM; Santana E Silva Cardoso FF; Mundim IM; Souza Teixeira L; Gomes SA; Bonfim RR; Pianetti GA
    J Mass Spectrom; 2011 Sep; 46(9):943-8. PubMed ID: 21915959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of levodopa, carbidopa and their metabolites in human plasma and urine samples using LC-EC.
    Sagar KA; Smyth MR
    J Pharm Biomed Anal; 2000 Apr; 22(3):613-24. PubMed ID: 10766378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous measurement of L-dopa, its metabolites and carbidopa in plasma of parkinsonian patients by improved sample pretreatment and high-performance liquid chromatographic determination.
    Lucarelli C; Betto P; Ricciarello G; Giambenedetti M; Corradini C; Stocchi F; Belliardo F
    J Chromatogr; 1990 Jul; 511():167-76. PubMed ID: 2211908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous monitoring of levodopa, dopamine and their metabolites in skeletal muscle and subcutaneous tissue in different pharmacological conditions using microdialysis.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    J Pharm Biomed Anal; 1993 Jul; 11(7):577-85. PubMed ID: 8399532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a simple and sensitive method for quantification of levodopa and carbidopa in rat and monkey plasma using derivatization and UPLC-MS/MS.
    Junnotula V; Licea-Perez H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():47-53. PubMed ID: 23548675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
    Rose S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of levodopa and carbidopa in rat plasma by LC-MS/MS: The key role of ion-pairing reversed-phase chromatography.
    Chi J; Ling Y; Jenkins R; Li F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1054():1-9. PubMed ID: 28412665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit.
    Tolokán A; Klebovich I; Balogh-Nemes K; Horvai G
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):201-7. PubMed ID: 9367209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED.
    Bugamelli F; Marcheselli C; Barba E; Raggi MA
    J Pharm Biomed Anal; 2011 Feb; 54(3):562-7. PubMed ID: 21035976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement.
    Tohgi H; Abe T; Yamazaki K; Saheki M; Takahashi S; Tsukamoto Y
    Neurosci Lett; 1995 Jun; 192(3):165-8. PubMed ID: 7566641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.
    Benetello P; Furlanut M; Zara G; Baraldo M; Hassan E
    Eur Neurol; 1993; 33(1):69-73. PubMed ID: 8440292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.